OMER (Omeros Corporation) Stock Financials & Earnings | Market Cap Arena

OMER (Omeros Corporation) Stock Financials & Earnings | Market Cap Arena

OMEROmeros Corporation

Mkt Cap$835M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$121M

EPS (TTM)-$2.02

Free Cash Flow (TTM)-$105M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q4 2025 · Mar 30

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$40M
Q1 23	$0	$0	-$36M
Q2 23	$0	$0	-$41M
Q3 23	$0	$0	-$48M
Q4 23	$0	-$205K	-$40M
Q1 24	$0	-$204K	-$39M
Q2 24	$0	$0	-$59M
Q3 24	$0	$0	-$35M
Q4 24	$0	-$301K	-$36M
Q1 25	$0	$0	-$35M
Q2 25	$0	-$10M	-$32M
Q3 25	$0	$0	-$26M

Valuation

Quarter	P/S	P/E
Q4 22	—	17.6x
Q1 23	—	17.9x
Q2 23	—	20.7x
Q3 23	—	41.8x
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q1 25	—	—
Q2 25	—	—
Q3 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$25M	-$25M
Q1 23	$175M	$175M
Q2 23	-$32M	-$33M
Q3 23	-$33M	-$33M
Q4 23	-$35M	-$35M
Q1 24	-$42M	-$42M
Q2 24	-$46M	-$46M
Q3 24	-$32M	-$32M
Q4 24	-$29M	-$29M
Q1 25	-$36M	-$36M
Q2 25	-$22M	-$22M
Q3 25	-$18M	-$18M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$13K
Q1 23	$0
Q2 23	$275K
Q3 23	$33K
Q4 23	$118K
Q1 24	$58K
Q2 24	$80K
Q3 24	$1K
Q4 24	$26K
Q1 25	$41K
Q2 25	$13K
Q3 25	$11K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	+100.0%	+92.5%
Q1 23	—	+1.9%
Q2 23	—	+9.2%
Q3 23	—	-5.1%
Q4 23	—	-0.9%
Q1 24	—	+9.3%
Q2 24	—	+44.6%
Q3 24	—	-26.5%
Q4 24	—	-10.3%
Q1 25	—	-10.4%
Q2 25	—	-45.3%
Q3 25	—	-25.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$0	—
Q1 23	$3M	—
Q2 23	$3M	—
Q3 23	$0	—
Q4 23	$0	—
Q1 24	$3M	—
Q2 24	$0	—
Q3 24	$3M	—
Q4 24	$2M	—
Q1 25	$0	—
Q2 25	$2M	—
Q3 25	$2M	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 22	$27M	$14M	—
Q1 23	$25M	$11M	—
Q2 23	$30M	$11M	—
Q3 23	$32M	$16M	—
Q4 23	$29M	—	$11M
Q1 24	$27M	$12M	—
Q2 24	$45M	$14M	—
Q3 24	$24M	$11M	—
Q4 24	$23M	—	$12M
Q1 25	$24M	$11M	—
Q2 25	$22M	—	—
Q3 25	$16M	—	$10M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$11M	$184M	$195M
Q1 23	$4M	$368M	$371M
Q2 23	$7M	$335M	$341M
Q3 23	$31M	$280M	$310M
Q4 23	$7M	$165M	$172M
Q1 24	$2M	$229M	$230M
Q2 24	$2M	$157M	$159M
Q3 24	$2M	$122M	$123M
Q4 24	$3M	$87M	$90M
Q1 25	$4M	$48M	$52M
Q2 25	$2M	$27M	$29M
Q3 25	$2M	$34M	$36M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	63M	+0.1%
Q1 23	63M	+0.1%
Q2 23	63M	+0.0%
Q3 23	63M	+0.0%
Q4 23	62M	-0.7%
Q1 24	59M	-5.8%
Q2 24	58M	-1.5%
Q3 24	58M	+0.0%
Q4 24	58M	+0.4%
Q1 25	58M	-0.2%
Q2 25	59M	+0.9%
Q3 25	66M	+13.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	$21K	75
FY 14	$5K	103
FY 15	$83K	162
FY 16	$270K	154
FY 17	$375K	173
FY 18	$127K	236
FY 19	$2M	64
FY 20	$0	63
FY 21	$0	213
FY 22	$0	196
FY 23	$0	198
FY 24	$0	202